Allopurinol Tablet
Product Images NDC 51655-968

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 51655-968). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 968 52 Master Bottle Label Approval Rev A 04 22)

NDC 51655-968-52 is a prescription-only medication containing Allopurinol tablets USP in 300mg strength. It is advised to store the tablets at 20° - 25°C (687 - 77°F), labeled as USP Controlled Room Temperature, and keep out of reach of children in the original container. The tablets have been repackaged from 53489-157-XX and do not contain any non-English characters.*

FDA Label Image

Structure (Allopurinol 01)

FDA Label Image

Figure (Allopurinol 02)

Allopurinol and Oxipurinol are chemical compounds belonging to the purine analogue class of medications. Allopurinol is a pyrazolo-pyrimidine, while Oxipurinol is a purine derivative. Both compounds are used to treat elevated uric acid levels in the blood and to prevent gout attacks. They inhibit the enzyme xanthine oxidase, which is involved in the production of uric acid, thereby reducing its levels. Allopurinol is converted to Oxipurinol in the body and both are excreted in urine.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.